Potential usefulness of the chimaeric type 1/type 2 poliovirus, V510 in universal reduction of poliomyelitis morbidity.
Arya
S C
SC
D002980:Climate; D006801:Humans; D007167:Immunotherapy; D011051:Poliomyelitis / Q000517:prevention & control*; D011054:Poliovirus Vaccine, Inactivated / Q000627:therapeutic use*; D014614:Vaccines, Synthetic / Q000627:therapeutic use*
D011054:Poliovirus Vaccine, Inactivated; D014614:Vaccines, Synthetic